Adoptive transfer of serum from vaccinated BALB/c mice to TUBO tumor-bearing mice resulted in significantly delayed tumor growth and showed considerable presence of anti-HER2/neu antibodies which were not observed upon deletion of CD4+ T cells (138), reinforcing the therapeutic benefits of anti-oncodriver antibodies and significance of CD4+ T cells. The gene discussed is ERBB2; the disease is neoplasm.